sipi 549 has been researched along with lidocaine in 1 studies
| Studies (sipi 549) | Trials (sipi 549) | Recent Studies (post-2010) (sipi 549) | Studies (lidocaine) | Trials (lidocaine) | Recent Studies (post-2010) (lidocaine) |
|---|---|---|---|---|---|
| 18 | 0 | 0 | 26,090 | 5,904 | 5,591 |
| Protein | Taxonomy | sipi 549 (IC50) | lidocaine (IC50) |
|---|---|---|---|
| Sodium channel protein type 4 subunit alpha | Homo sapiens (human) | 2 |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Fan, XR; Ma, JH; Xing, JL; Zhang, PH | 1 |
1 other study(ies) available for sipi 549 and lidocaine
| Article | Year |
|---|---|
Blocking effect of methylflavonolamine on human Na(V)1.5 channels expressed in Xenopus laevis oocytes and on sodium currents in rabbit ventricular myocytes.
Topics: Action Potentials; Animals; Anti-Arrhythmia Agents; Cells, Cultured; Female; Flavonols; Heart Ventricles; Humans; Lidocaine; Male; Muscle Proteins; Myocytes, Cardiac; NAV1.5 Voltage-Gated Sodium Channel; Oocytes; Rabbits; Sodium; Sodium Channels; Xenopus laevis | 2010 |